Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 20/4/2018
SIETES contiene 92261 citas

 
 
 1 a 20 de 2134 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Joseph A. Panel recommends FDA approval of epilepsy drug derived from marijuana. DIA Daily 2018:1. [Ref.ID 102518]
2. Cita con resumen
Darrow JJ, Avorn J, Kesselheim AS. The FDA breakthrough-drug designation - Four years of experience. N Engl J Med 2018;378:16 de abril. [Ref.ID 102515]
4. Cita con resumen
Anónimo. Hallucinations and pimavanserin (NUPLAZID), a new kind of drug for psychosis. ISMP Quarter Watch 2018:6. [Ref.ID 102509]
5. Cita con resumen
Feuerstein A. Alkermes stumbles as FDA refuses to review depression drug. STAT Daily Recap 2018:6. [Ref.ID 102496]
6. Cita con resumen
The editors. FDA advisers recommend approval of non-opioid drug for opioid withdrawal. Physician's First Watch 2018:4. [Ref.ID 102485]
7. Cita con resumen
Begley S, Empinado H. STAT Plus: CAR-T is a personalized attack on cancer. Here’s how it works. STAT Daily Recap 2018:6. [Ref.ID 102483]
8. Cita con resumen
9. Cita con resumen
10.
Whitlock J. Cannabis-derived drug granted priority review. San Diego Business Journal 2018:2 de enero. [Ref.ID 102441]
11. Cita con resumen
Johansen ME. Gabapentinoid use in the United States 2002 through 2015. JAMA Intern Med 2018:2 de enero. [Ref.ID 102440]
12.Tiene citas relacionadas Cita con resumen
Jonker CJ, van den Berg HM, Kwa MSG, Hoes AW, Mol PGM. Registries supporting new drug applications. Pharmacoepidemiol Drug Saf 2017;27:1451-7. [Ref.ID 102187]
13. Cita con resumen
Anónimo. EMA investigating whether ulipristal acetate can damage the liver. DIA Daily 2017:8. [Ref.ID 102159]
14. Cita con resumen
Santoro A, Genov G, Spooner A, Raine J, Arlett P. Promoting and protecting public health: how the European Union pharmacovigilance system works. Drug Saf 2017;40:855-69. [Ref.ID 102075]
15. Cita con resumen
Woloshin S, Schwartz LM, White B, Moore TJ. The fate of FDA postapproval studies. N Engl J Med 2017;377:1114-7. [Ref.ID 102072]
18.Enlace a cita original Cita con resumen
Prasad V, Mailan S. Research and development spending to bring a single cancer drug to market and revenues after approval. JAMA Intern Med 2017;177:1569-75. [Ref.ID 102051]
19. Cita con resumen
Anónimo. EMA panel recommends approval of GSK’s triple inhaler to treat COPD. DIA Daily 2017:2. [Ref.ID 102050]
20. Cita con resumen
Anónimo. FDA Approves CAR-T therapy for treatment of childhood leukemia. DIA Daily 2017:1. [Ref.ID 102036]
Seleccionar todas
 
 1 a 20 de 2134 siguiente >>